Chronic diseases “as urgent as climate change,” says Novo Nordisk CSO
Chronic diseases such as obesity are as urgent as global warming and climate change, according to Novo Nordisk’s chief scientific …
Post
-
-
Enara Bio secures $32.5m for ‘Dark Antigen’ cancer therapies
Enara Bio has raised $32.5m in a Series B financing round to advance its platform shining a light on cancer-specific …
-
Healthcare Payers for the Pharmaceutical Industry
Factors such as increasing access to health information, the introduction of new medical treatments and technologies and the spike in …
-
ImmunoPrecise and Biotheus partner on bispecific antibodies to treat cancer
ImmunoPrecise Antibodies, an AI-driven biotherapeutic research and technology company, has entered into a material transfer and evaluation agreement (MTEA) with …
-
Novaliq and Laboratoires Théa announce EC approval for dry eye disease therapy
Novaliq and Laboratoires Théa have announced approval from the European Commission (EC) for Vevizye (ciclosporin 0.1% eye drops solution) for …
-
Gilead signs agreements to facilitate access to HIV prevention drug
Gilead Sciences has announced the signing of voluntary licencing agreements with six generic pharmaceutical manufacturers to facilitate access to lenacapavir, …
-
Eli Lilly to invest $4.5bn for drug manufacturing and trial medicine production
Eli Lilly has announced a $4.5bn investment to establish the Lilly Medicine Foundry for drug production and manufacturing medicines for …
-
Social media algorithms are driving the GLP-1 drugs boom
A rapid growth in demand for GLP-1 receptor agonists (RAs) medications has increased scrutiny around the relationship between patient-led recommendations …
-
Triveni scores $115m to expand immunology pipeline
Triveni Bio has secured $115m in a Series B funding round to advance its preclinical antibody candidates for immunological and …
-
Shattuck Labs stock craters following pipeline and job cuts
Shattuck Labs has dropped by nearly 45% after it announced plans to reduce its headcount and discontinue its lead cancer …
-
Cloud Computing in the Pharmaceutical Industry
Cloud computing in the pharmaceutical industry has grown enormously in recent years and shows no signs of slowing. It has …
-
Potential for peptides to replace antibodies in radiopharma, says WuXi AppTec exec
Amid the boom in the radiopharmaceutical space, peptide-based therapeutics could be set to outmanoeuvre antibody-based counterparts, according to WuXi AppTec’s …
-
Exscientia outline robot and AI use in drug discovery workflow
As AI continues to disrupt the healthcare industry, more pharma companies are using algorithms to design drug molecules. AI-driven pharma tech …
-
LoQus23 secures $43m to advance Huntington’s Disease therapy
LoQus23 closed a round of Series A financing to advance development of its lead candidate for Huntington’s Disease. The Cambridge, UK-based …
-
Retail Pharmacies for the Pharmaceutical Industry
Increasing diagnosis of chronic diseases is expected to lead to fast growth in retail pharmacies. The rising incidence of long-standing …